ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,00%
Dow Jones
39 056,39
0,44%
DAX
18 488,07
0,00%
Brent Oil
83,725
0,20%
Bitcoin
61 507,16
0,54%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Qiagen NV (QGEN)

  7. Qiagen NV (QGEN) Actualités

QGEN

Qiagen NV (QGEN)

Qiagen NV
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:QGEN
DateHeureSourceTitreSymboleSociété
07/05/202422h05GlobeNewswire Inc.QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensicsNYSE:QGENQiagen NV
02/05/202422h05GlobeNewswire Inc.QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsNYSE:QGENQiagen NV
29/04/202422h05GlobeNewswire Inc.QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceNYSE:QGENQiagen NV
24/04/202422h05GlobeNewswire Inc.QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceNYSE:QGENQiagen NV
09/04/202415h48GlobeNewswire Inc.QIAGEN N.V. to release results for Q1 2024 and hold webcastNYSE:QGENQiagen NV
03/04/202422h05GlobeNewswire Inc.QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024NYSE:QGENQiagen NV
25/03/202421h05GlobeNewswire Inc.QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemNYSE:QGENQiagen NV
18/03/202421h05GlobeNewswire Inc.QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsNYSE:QGENQiagen NV
11/03/202410h59GlobeNewswire Inc.QIAGEN announces Form 20-F annual report filing for 2023 resultsNYSE:QGENQiagen NV
27/02/202423h44GlobeNewswire Inc.QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discoveryNYSE:QGENQiagen NV
27/02/202422h05GlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
08/02/202415h47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
06/02/202422h05GlobeNewswire Inc.QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitabilityNYSE:QGENQiagen NV
25/01/202416h00GlobeNewswire Inc.QIAGEN announces partnership with Penn State University to advance microbiome sciencesNYSE:QGENQiagen NV
23/01/202422h13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:QGENQiagen NV
18/01/202422h05GlobeNewswire Inc.QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 millionNYSE:QGENQiagen NV
11/01/202413h53GlobeNewswire Inc.QIAGEN N.V. to release results for Q4 2023 and hold webcastNYSE:QGENQiagen NV
08/01/202408h00GlobeNewswire Inc.QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular SystemsNYSE:QGENQiagen NV
07/01/202419h07GlobeNewswire Inc.QIAGEN announces plans to return approximately $300 million to shareholdersNYSE:QGENQiagen NV
04/01/202422h05GlobeNewswire Inc.QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics businessNYSE:QGENQiagen NV
03/01/202408h00GlobeNewswire Inc.QIAGEN expands business in Middle East with new regional headquarters and major projectsNYSE:QGENQiagen NV
30/11/202322h05GlobeNewswire Inc.DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogyNYSE:QGENQiagen NV
15/11/202322h05GlobeNewswire Inc.QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolationNYSE:QGENQiagen NV
09/11/202322h05GlobeNewswire Inc.QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customersNYSE:QGENQiagen NV
06/11/202322h05GlobeNewswire Inc.QIAGEN launches complete Sample to Insight workflow for microbiome researchNYSE:QGENQiagen NV
02/11/202313h00PR Newswire (US)QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
30/10/202321h05GlobeNewswire Inc.QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CERNYSE:QGENQiagen NV
26/10/202314h00GlobeNewswire Inc.QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancerNYSE:QGENQiagen NV
09/10/202317h14GlobeNewswire Inc.QIAGEN N.V. to release results for Q3 2023 and hold webcastNYSE:QGENQiagen NV
04/10/202322h05GlobeNewswire Inc.QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virusNYSE:QGENQiagen NV
 Showing the most relevant articles for your search:NYSE:QGEN

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
EU
BN
Danone
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
COIN
ETHUSD
Ethereum
EU
ML
Michelin
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
EU
RNO
Renault
EU
LR
Legrand
EU
ACA
Credit Agricole
EU
VK
Vallourec
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés